Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 06
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
60,000
-26.09%
|
$3,180,000
$53.58 P/Share
|
|
Aug 01
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
250
-0.09%
|
$16,000
$64.44 P/Share
|
|
Aug 01
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.09%
|
$2,750
$11.53 P/Share
|
|
Jul 31
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
26,350
-8.64%
|
$1,765,450
$67.0 P/Share
|
|
Jul 31
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,350
+2.15%
|
$237,150
$9.32 P/Share
|
|
Jul 28
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.63%
|
$149,176
$58.7 P/Share
|
|
Jul 24
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,100
-0.75%
|
$119,700
$57.52 P/Share
|
|
Jul 24
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+0.74%
|
$10,500
$5.01 P/Share
|
|
Jul 23
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,750
-4.7%
|
$770,000
$56.0 P/Share
|
|
Jul 23
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+1.51%
|
$96,250
$7.79 P/Share
|
|
Jul 21
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
125,335
-24.27%
|
$6,141,415
$49.5 P/Share
|
|
Jul 21
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+19.11%
|
$250,670
$2.43 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-10.06%
|
$2,376,700
$50.53 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,792
-2.94%
|
$139,600
$50.58 P/Share
|
|
Jul 14
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-17.64%
|
$544,307
$47.7 P/Share
|
|
Jul 14
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,587
+10.36%
|
$37,935
$5.01 P/Share
|
|
Jul 14
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.6%
|
$120,884
$47.82 P/Share
|
|
Jul 07
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-16.63%
|
$532,726
$46.67 P/Share
|
|
Jul 07
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+8.46%
|
$32,185
$5.01 P/Share
|
|
Jun 30
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.57%
|
$128,600
$50.5 P/Share
|
|
Jun 23
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,107
-26.77%
|
$1,086,029
$47.25 P/Share
|
|
Jun 17
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
8,485
-92.26%
|
$500,615
$59.75 P/Share
|
|
Jun 17
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.55%
|
$151,748
$59.75 P/Share
|
|
Jun 17
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
65,110
-22.02%
|
$3,776,380
$58.98 P/Share
|
|
Jun 17
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,102
-5.78%
|
$1,009,018
$59.75 P/Share
|
|
Jun 16
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,451
-3.18%
|
$305,256
$56.8 P/Share
|
|
Jun 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-12.84%
|
$7,303,239
$57.07 P/Share
|
|
Jun 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+17.18%
|
$250,670
$2.43 P/Share
|
|
Jun 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-8.55%
|
$2,661,904
$56.67 P/Share
|
|
Jun 13
2025
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,787
-48.86%
|
$483,285
$55.48 P/Share
|
|
Jun 13
2025
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,984
+50.0%
|
-
|
|
Jun 13
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,282
-11.96%
|
$1,280,510
$55.48 P/Share
|
|
Jun 13
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,420
+17.55%
|
-
|
|
Jun 13
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
58,023
-40.2%
|
$3,191,265
$55.48 P/Share
|
|
Jun 13
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,199
+42.16%
|
-
|
|
Jun 13
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90,672
-35.74%
|
$4,986,960
$55.48 P/Share
|
|
Jun 13
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
164,368
+39.32%
|
-
|
|
Jun 13
2025
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,166
-14.0%
|
$2,649,130
$55.48 P/Share
|
|
Jun 13
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
87,106
+20.23%
|
-
|
|
Jun 13
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,177
-2.62%
|
$339,735
$55.48 P/Share
|
|
Jun 13
2025
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,521
+6.54%
|
-
|
|
Jun 13
2025
|
Anja Manuel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,040
+28.67%
|
-
|
|
Jun 13
2025
|
Christopher D Payne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,040
+33.45%
|
-
|
|
Jun 12
2025
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+5.34%
|
-
|
|
Jun 12
2025
|
Kare Schultz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,118
+50.0%
|
-
|
|
Jun 12
2025
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+10.73%
|
-
|
|
Jun 12
2025
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+4.33%
|
-
|
|
Jun 12
2025
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+13.38%
|
-
|
|
Jun 12
2025
|
Deborah M. Autor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,175
+50.0%
|
-
|
|
Jun 12
2025
|
Anja Manuel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+39.95%
|
-
|